Germantown, MD, October 15, 2010 – Frontier is pleased to announce the addition of Joseph J. Stashick, RQAP-GLP as the new Director of Quality Assurance.  Mr. Stashick will be based in Frontier’s Chengdu, China laboratory, overseeing the Quality Assurance Department.

Mr. Stashick has over 20 years experience in the research field, and over 14 years experience in Quality Assurance management with experience in GLP, GMP, ISO 9001 and ISO 13485.  Prior to joining the staff of Frontier he was employed by ExonHit Therapeutics, where he served as Manager of Quality Assurance.  While employed by ExonHit, Joe was responsible for the development of a GLP compliant program, from the ground up.

Mr. Stashick’s strong background in Quality Assurance will enhance Frontier’s reputation as a leading CRO in China.  In addition to his years of experience, Joe has earned the distinction of being recognized as a Registered Quality Assurance Professional by the Society of Quality Assurance (2007 through 2013), among other professional affiliations.

“Joe’s experience in Quality Assurance will increase Frontier’s emphasis on exceptional, quality data, and his unwavering commitment to quality will afford him great insight in continuously improving the company’s high quality standards,” said Chief Operating Officer of Frontier, Li Tian, PhD.

Mr. Stashick earned his BS in Biochemistry from the University of Maryland in College Park, Maryland.

About Frontier BioSciences, Inc.  Frontier BioSciences, Inc. is headquartered in the US with laboratory facilities in Chengdu and Kunming China.  Frontier provides a full spectrum of drug discovery and development resources to biotechnology and pharmaceutical industries in the scientific disciplines of GLP-compliant toxicology, developmental and reproductive toxicology, pharmacology, genetic toxicology, pathology, analytical chemistry and international regulatory guidance